[Adenocarcinoma of the pancreas: are CA 19-9 assays useful?].
The CA 19-9 assay is not a sensitive examination that is useful for the diagnosis of a resectable pancreatic tumor. It is not a specific examination for the presence of a tumor or malignancy. It is not a good prognostic indicator. Its rate of prescription should be reduced by several orders of magnitude.
Lévy
Philippe
P
Pôle des maladies de l'appareil digestif, Service de gastroentérologie-pancréatologie, AP-HP, Hôpital Beaujon, F-92118 Clichy Cedex, France. philippe.levy@bjn.aphp.fr
D000230:Adenocarcinoma / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D018395:CA-19-9 Antigen / Q000097:blood*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000097:blood*; D012680:Sensitivity and Specificity
D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen